Product Information
ALBUTEROL HFA 90 MCG INHALER is a generic product labeled by Cipla USA Inc., priced at $2.1200 per GM under NDC 69097014260. Its NADAC has been published 331 times since Jun 3, 2020.
FDA first approved this application on Apr 8, 2020. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
90 ug/1
Manufacturer
Cipla USA Inc.NDC
69097014260
Classification
Generic
Dosage Form
INHALANT
Route
RESPIRATORY (INHALATION)
Effective Date
9/23/2026
Active Ingredients
ALBUTEROL SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA209959FDA Approved
4/8/2020
TE Code
AB1
On Market Since
4/8/2020
Pharmacological Classes
Price Statistics
The NADAC for ALBUTEROL HFA 90 MCG INHALER has been published 331 times since Jun 3, 2020, and over the history we have for it it has declined 57.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.1200 per GM |
|---|---|
| All-time high | $5.2306 (Oct 14, 2020) |
| All-time low | $2.0480 (Nov 20, 2024) |
| 52-week high | $2.2422 |
| 52-week low | $2.1200 |
| Median price | $3.1105 |
| Average price | $3.2702 |
| Largest weekly change | -21.8% (Nov 20, 2024) |
| Weeks tracked | 331 |
| Tracking since | Jun 3, 2020 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Cipla USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
albuterol sulfate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
beta2-Adrenergic Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ALBUTEROL HFA 90 MCG INHALER?
The current National Average Drug Acquisition Cost (NADAC) for ALBUTEROL HFA 90 MCG INHALER, manufactured by Cipla USA Inc., is $2.1200 per GM (NDC 69097014260), effective Sep 30, 2026.
How has the price of ALBUTEROL HFA 90 MCG INHALER changed over time?
Over the history we have for it, the NADAC for ALBUTEROL HFA 90 MCG INHALER has declined 57.3%. It has been tracked across 331 weekly CMS publications since Jun 3, 2020.
What are the highest and lowest recorded NADAC prices for ALBUTEROL HFA 90 MCG INHALER?
Since Jun 3, 2020, the NADAC for ALBUTEROL HFA 90 MCG INHALER has ranged from a low of $2.0480 (Nov 20, 2024) to a high of $5.2306 (Oct 14, 2020), with a median of $3.1105 per GM.
Are there cheaper alternatives to ALBUTEROL HFA 90 MCG INHALER?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as ALBUTEROL HFA 90 MCG INHALER in a comparable dosage form, but none are currently priced below it.
Who manufactures ALBUTEROL HFA 90 MCG INHALER?
ALBUTEROL HFA 90 MCG INHALER (NDC 69097014260) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.